Condensed Statement of Shareholders' Deficiency - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2020	Jul. 31, 2019	Jul. 31, 2020	Jul. 31, 2019
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning Balance	$ (764,019)	$ (674,516)	$ (743,420)	$ (655,736)
Net loss	(20,628)	(19,886)	(41,227)	(38,666)
Ending Balance	$ (784,647)	$ (694,402)	$ (784,647)	$ (694,402)
Common Stock
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning Balance (in shares)	1,899,575	1,899,575	1,899,575	1,899,575
Beginning Balance	$ 1,900	$ 1,900	$ 1,900	$ 1,900
Ending Balance (in shares)	1,899,575	1,899,575	1,899,575	1,899,575
Ending Balance	$ 1,900	$ 1,900	$ 1,900	$ 1,900
Additional Paid-in Capital
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning Balance	8,418,684	8,418,684	8,418,684	8,418,684
Ending Balance	8,418,684	8,418,684	8,418,684	8,418,684
Accumulated Deficit
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning Balance	(9,184,603)	(9,095,100)	(9,164,004)	(9,076,320)
Net loss	(20,628)	(19,886)	(41,227)	(38,666)
Ending Balance	$ (9,205,231)	$ (9,114,986)	$ (9,205,231)	$ (9,114,986)